Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

4.5K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.5K
Coagulation01:09

Coagulation

3.9K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
3.9K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

586
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
586
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

3.1K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.1K
Structure and Function of Platelets01:18

Structure and Function of Platelets

937
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
937
Introduction to Hemostasis01:05

Introduction to Hemostasis

4.7K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
4.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Packaging of supplemented urokinase into alpha granules of in vitro-grown megakaryocytes for targeted nascent clot lysis.

Blood advances·2024
Same author

Plasma growth factors maintain constitutive translation in platelets to regulate reactivity and thrombotic potential.

Blood advances·2024
Same author

Factor VIII trafficking to CD4+ T cells shapes its immunogenicity and requires several types of antigen-presenting cells.

Blood·2023
Same author

Factor IXa variants resistant to plasma inhibitors enhance clot formation in vivo.

Blood·2023
Same author

Blood coagulation factor X: molecular biology, inherited disease, and engineered therapeutics.

Journal of thrombosis and thrombolysis·2021
Same author

Activated protein C has a regulatory role in factor VIII function.

Blood·2021

相关实验视频

Updated: May 23, 2025

Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes
12:24

Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes

Published on: June 3, 2014

12.2K

血液凝固因子IX:结构,功能和调节

Lacramioara Ivanciu1,2, Rodney M Camire1,2

  • 1Division of Hematology and the Raymond G. Perelman Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

IUBMB life
|May 22, 2025
PubMed
概括

本综述总结了血液凝固因子IX的生物学,这是内在途径中的关键蛋白质. 它详细介绍了XIX因素.

关键词:
第九个因素. 第九章 IXa 第九章 IXa 第九章 IXa血液静止 血液静止 血液静止监管 监管 监管 监管 监管 监管细胞因子转化为蛋白酶的过渡过程

更多相关视频

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

5.9K
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

18.9K

相关实验视频

Last Updated: May 23, 2025

Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes
12:24

Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes

Published on: June 3, 2014

12.2K
Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

5.9K
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

18.9K

科学领域:

  • 生物化学 生物化学
  • 分子遗传学 分子遗传学
  • 生理学 生理学 生理学

背景情况:

  • 血液凝固因子IX对于内在途径至关重要,产生XA因子并导致血栓形成.
  • 超过50年的广泛研究已经阐明了因子IX的生物学,生理学,病理学,生物化学和分子遗传学.

研究的目的:

  • 审查目前关于因子IX生物学的知识.
  • 专注于第九因子结构-功能关系,基因结构和调节.

主要方法:

  • 对因子IX现有研究的文献综述.
  • 综合有关第九因子演变,调节,功能和结构影响的信息.

主要成果:

  • 详细了解因子IX基因和蛋白质进化.
  • 了解凝血级联中的XIX因子的调节和功能.
  • 了解结构变化如何影响因子IX的功能.

结论:

  • 第九因子的生物学是复杂的,涉及复杂的结构功能关系.
  • 了解第九因子基因结构和调节对于理解凝血至关重要.